Products Affected - Description
There are no products affected.
Reason for the Shortage
- These products are also known as adult tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccines.
- Sanofi-Pasteur has Adacel vials in short supply due to increased demand.
- Sanofi-Pasteur updated the NDC numbers on the individual vials and syringes (unit of use). The NDC numbers on the outside cartons (unit of sale) remain the same.
- Adult Tetanus and Diphtheria Toxoids Adsorbed (Td) (Tenivac, Sanofi-Pasteur) is not affected by this shortage.
Adacel Vaccine, Sanofi-Pasteur
0.5 mL, single dose syringes, package of 10 (NDC 49281-0400-15)
0.5 mL, single dose vials, package of 10, unit of sale (NDC 49281-0400-10), unit of use (NDC 49281-0400-58)
Boostrix Vaccine, GlaxoSmithKline
0.5 mL, single dose syringes, 10 count (NDC 58160-0842-52)
0.5 mL, single dose vials, 10 count (NDC 58160-0842-11)
Estimated Resupply Dates
All presentations are available.
July 28, May 20, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins